Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Apr;66(4):1403-6.
doi: 10.1086/302833. Epub 2000 Mar 14.

Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene

Affiliations

Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene

M D Taylor et al. Am J Hum Genet. 2000 Apr.

Abstract

We have identified a family afflicted over multiple generations with posterior fossa tumors of infancy, including central nervous system (CNS) malignant rhabdoid tumor (a subset of primitive neuroectodermal tumors, or PNET) and choroid plexus carcinoma. Various hereditary tumor syndromes, including Li-Fraumeni syndrome, Gorlin syndrome, and Turcot syndrome, have been linked to increased risk of developing CNS PNETs and choroid plexus tumors. Malignant rhabdoid tumors of the CNS and kidney show loss of heterozygosity at chromosome 22q11. The hSNF5 gene on chromosome 22q11 has recently been identified as a candidate tumor-suppressor gene in sporadic CNS and renal malignant rhabdoid tumors. We describe a family in which both affected and some unaffected family members were found to have a germline splice-site mutation of the hSNF5 gene, leading to exclusion of exon 7 from the mature cDNA and a subsequent frameshift. Tumor tissue shows loss of the wild-type hSNF5 allele, in keeping with a tumor-suppressor gene. These findings suggest that germline mutations in hSNF5 are associated with a novel autosomal dominant syndrome with incomplete penetrance that predisposes to malignant posterior fossa brain tumors in infancy.

PubMed Disclaimer

Figures

Figure  1
Figure 1
Pedigree showing posterior fossa tumors in one family over two generations with an unaffected carrier.
Figure  2
Figure 2
RT-PCR of a portion of the hSNF5 cDNA, showing the expected wild-type product from normal brain and from paternal and sibling (brother) wbc cDNA. Maternal and proband wbc cDNA shows wild-type and mutant transcripts, with an intervening heteroduplex. Tumor cDNA shows only the mutant transcript, with loss of the wild-type allele.
Figure  3
Figure 3
Sequencing of exon 7 of hSNF5, showing a G→A mutation (double arrow) in the proband’s tumor, proband’s germline, and mother’s germline DNA. Leukocyte DNA from proband’s father and brother show the wild-type sequence. The proband’s tumor and her uncle’s tumor (Uncle) show the same G→A mutation.

References

Electronic-Database Information

    1. Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/omim/ (for hSNF5 [OMIM 601607])

References

    1. Biegel JA, Allen CS, Kawasaki K, Shimizu N, Budarf ML, Bell CJ (1996) Narrowing the critical region for a rhabdoid tumor locus in 22q11. Genes Chromosomes Cancer 16:94–105 - PubMed
    1. Biegel JA, Rorke LB, Packer RJ, Emanuel BS (1990) Monosomy 22 in rhabdoid or atypical tumors of the brain. J Neurosurg 73:710–714 - PubMed
    1. Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74–79 - PubMed
    1. Bigner SH, Friedman HS, Vogelstein B, Oakes WJ, Bigner DD (1990) Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res 50:2347–2450 (erratum [1990] Cancer Res 50:3809) - PubMed
    1. Bonnin JM, Rubinstein LJ, Palmer NF, Beckwith JB (1984) The association of embryonal tumors originating in the kidney and in the brain: a report of seven cases. Cancer 54:2137–2146 - PubMed

Publication types

MeSH terms